ReviewPharmacogenomics and personalized medicine2018

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients.

Hironori Uruga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.